35 sites active and enrolling in pivotal Phase 3 study of Bria-IMT™ combination with immune ...
FDA has authorized the Expanded Access Policy (EAP) to help metastatic breast cancer patients in ...
ASCO 2018: Interview with Dr. Saveri Bhattacharya on the ongoing Ph I/IIa clinical trial with ...
Berkeley, CA and Vancouver, BC – December 21, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...
Click here to read more ...
Expanding Breast Cancer Treatment Options: A Q&A with BriaCell on their Cancer Vaccine and their ...
Berkeley, CA and Vancouver, BC – October 13, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...
The Wall Street Analyzer Interview with Dr. Williams – 2017 ...
Accessibility Tools